• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The role of MR imaging in the selection of therapy for prostate cancer.

作者信息

D'Amico A V

机构信息

Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Magn Reson Imaging Clin N Am. 1996 Aug;4(3):471-9.

PMID:8873014
Abstract

Combined modality staging is a methodology in which all of the pretreatment clinical factors that are found to have independent prognostic significance on multivariable analysis for predicting a given outcome (e.g., pathologic stage) are used to determine the initial management. This method of staging provides an optimized assessment of the pathologic extent of local disease prior to management, and therefore is better able to define those patients in whom local only therapy is likely to be curative. Knowing more about the pathologic extent of disease prior to therapy provides a rationale for patient selection in clinical trials that test new management strategies against the current standards. The preoperative endorectal coil MR imaging study results have been shown on multivariable analysis (which included PSA, clinical stage, and biopsy Gleason score) to provide statistically independent prognostic information about the outcomes of pathologic stage, margin status, postoperative PSA failure, and the prediction of local only failure in the positive margin patient.

摘要

相似文献

1
The role of MR imaging in the selection of therapy for prostate cancer.
Magn Reson Imaging Clin N Am. 1996 Aug;4(3):471-9.
2
[Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].[前列腺癌分期:直肠内磁共振成像、活检 Gleason 评分及术前前列腺特异性抗原水平联合信息的价值]
Rofo. 2006 Apr;178(4):385-90. doi: 10.1055/s-2006-926475.
3
Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.结合活检侧别与TNM分期的改良临床分期系统用于T1c和T2期前列腺癌男性患者:SEARCH数据库的结果
J Urol. 2003 Jun;169(6):2129-35. doi: 10.1097/01.ju.0000065763.21602.14.
4
External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.临床分期为T1-2期前列腺癌的体外放射治疗与根治性前列腺切除术:根据治疗前前列腺特异性抗原(PSA)水平和活检Gleason评分分层的治疗意义
Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87.
5
The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.前列腺穿刺活检癌灶在穿刺活检受累更严重一侧的百分比作为根治性前列腺切除术后前列腺特异性抗原复发的预测指标:来自共享平等准入区域癌症医院(SEARCH)数据库的结果
Cancer. 2003 Dec 1;98(11):2344-50. doi: 10.1002/cncr.11809.
6
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.前列腺穿刺活检标本中癌阳性核心的百分比强烈预测根治性前列腺切除术中的肿瘤分期和体积。
J Urol. 2000 Jan;163(1):174-8.
7
Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?穿刺活检 Gleason 评分为 7 分的前列腺癌:Gleason 评分 4+3 和 3+4 的预后差异是否独立于受累穿刺针数?
J Urol. 2002 Jun;167(6):2440-2.
8
Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.癌症阳性核心的百分比在预测前列腺癌根治术后癌症复发方面比前列腺特异性抗原是更好的术前预测指标。
J Urol. 2004 Apr;171(4):1492-9. doi: 10.1097/01.ju.0000118690.05943.c0.
9
Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.病理局限于器官的疾病男性患者根治性前列腺切除术后的生化复发:pT2a与pT2b对比
Cancer. 2004 Apr 15;100(8):1646-9. doi: 10.1002/cncr.20145.
10
Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.临床分期为T1c期前列腺癌患者病理分期的预测:新挑战
J Urol. 2002 Jul;168(1):100-4.